This is a preview of subscription content, log in via an institution to check access.
Reference
Njei B, et al. Cost-Effectiveness of Universal Hepatitis B Vaccination in U.S. Adults with Diabetes Mellitus: A Markov Simulation Model. 63rd Annual Meeting of the American Association for the Study of Liver Diseases : abstr. 343, 9 Nov 2012. Available from: URL: http://www.aasld.org/lm2012/2012/abstracts/Pages/default.aspx
Rights and permissions
About this article
Cite this article
Routine hep B vax in DM patients cost effective. PharmacoEconomics & Outcomes News 669, 8 (2013). https://doi.org/10.1007/s40274-013-0058-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0058-6